Guinea vs Niger: Cause of death, by non-communicable diseases, ages 5-14, female
Guinea
19.7%
in 2021
Niger
18.9%
in 2021
Guinea rank
158th
Niger rank
161st
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Guinea
- Niger
How they compare
Guinea currently reports 19.7% against 18.9% in Niger, a difference of 0.8%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Niger ahead.
Guinea ranks 158th and Niger ranks 161st of 184 countries.
Across the 3 decades both report, Guinea averaged higher in 2 and Niger in 1.
Head to head by decade
| Decade | Guinea | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.8% | 13.9% | 8.2% | Niger |
| 2010s | 18.8% | 17.1% | 1.7% | Guinea |
| 2020s | 20.7% | 18.7% | 2.0% | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Guinea or Niger?
- Guinea, at 19.7% against 18.9% in Niger as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Guinea and Niger?
- 0.8%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Niger?
- 6 years are reported by both, from 2000 to 2021.
- How do Guinea and Niger rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Guinea ranks 158th and Niger ranks 161st of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.